welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Increased MuTYH Mutation Frequency Among Dutch Families With Breast cancer and Colorectal Cancer
source: Breast cancer research and treatment
year: 2010
authors: Wasielewski M, Out A A, Vermeulen J, Nielsen M, van den Ouweland A, Tops C M, Wijnen J T, Vasen H F, Weiss M M, Klijn J G, Devilee P, Hes F J, Schutte M
summary/abstract:Homozygous and compound heterozygous MUTYH mutations predispose for MUTYH-associated polyposis (MAP). The clinical phenotype of MAP is characterised by the multiple colorectal adenomas and colorectal carcinoma. We previously found that female MAP patients may also have an increased risk for breast cancer. Yet, the involvement of MUTYH mutations in families with both breast cancer and colorectal cancer is unclear. Here, we have genotyped the MUTYH p.Tyr179Cys, p.Gly396Asp and p.Pro405Leu founder mutations in 153 Dutch families with breast cancer patients and colorectal cancer patients. Families were classified as polyposis, revised Amsterdam criteria positive (FCRC-AMS positive), revised Amsterdam criteria negative (FCRC-AMS negative), hereditary breast and colorectal cancer (HBCC) and non-HBCC breast cancer families. As anticipated, biallelic MUTYH mutations were identified among 13% of 15 polyposis families, which was significantly increased compared to the absence of biallelic MUTYH mutations in the population (P = 0.0001). Importantly, six heterozygous MUTYH mutations were identified among non-polyposis families with breast and colorectal cancer. These mutations were identified specifically in FCRC-AMS negative and in HBCC breast cancer families (11% of 28 families and 4% of 74 families, respectively; P = 0.02 for both groups combined vs. controls). Importantly, the 11% MUTYH frequency among FCRC-AMS negative families was almost fivefold higher than the reported frequencies for FCRC-AMS negative families unselected for the presence of breast cancer patients (P = 0.03). Together, our results indicate that heterozygous MUTYH mutations are associated with families that include both breast cancer patients and colorectal cancer patients, independent of which tumour type is more prevalent in the family.
organization: Erasmus University Medical CentreDOI: 10.1007/s10549-010-0801-7
read more full text source
expertly curated content related to this topic
-
MUTYH (mutY homolog (E. coli))Review on MUTYH (mutY homolog (E. coli))...
-
Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors̵...Colorectal cancer (CRC) is a leading cau...
-
Location in the Large Bowel Influences the APC Mutations Observed in FAP AdenomasThe right colon differs from the left, i...
-
Mutation Analysis of the APC Gene in Unrelated Korean Patients with FAP: Four Novel Mutations with Unusual PhenotypeGermline mutations within the adenomatou...
-
Oncogenic KRAS is not Necessary for Wnt Signalling Activation in APC-Associated FAP AdenomasRecent studies have suggested that APC l...
-
APC Germline Mutations in Individuals Being Evaluated for Familial Adenomatous Polyposis: A Review of the Mayo Clini...Inactivating APC mutations cause familia...
-
Risk Factors Predicting Intra-Abdominal Desmoids in Familial Adenomatous Polyposis: A Single Centre ExperienceBACKGROUND : Desmoids are myofibroblasti...